Latest News  

In Memoriam: Mart Mannik, MD

Mart Mannik, MD, professor emeritus, Division of Rheumatology at the University of Washington (UW), passed away on Wednesday, Aug. 22, 2018. Dr. Mannik was born… [Read More]

ACR Leaders Outline Advocacy Victories, Threats

CHICAGO—ACR leaders described a series of looming legislative and regulatory threats to rheumatologists and their patients—including the proposed collapsing of evaluation and management (E/M) coding… [Read More]

Gene Therapy for OA

Background & objective: One of the major challenges in the treatment of chronic joint diseases, such as osteoarthritis (OA), is the need to provide sustained… [Read More]

How to Engage Young Adult Patients

Gaps in healthcare are common between the ages of 17 and 21. But simple collaborations between adult and pediatric rheumatologists can go a long way to help young adults stay engaged in their rheumatology care… [Read More]

Mirtazapine Ineffective for Fibromyalgia

Mirtazapine has been prescribed off-label to fibromyalgia patients who have not responded to other treatments. However, a recent systemic review found no difference between mirtazapine and placebo for these patients, and any potential benefits from mirtazapine may not outweigh its potential harm, including drowsiness, weight gain and liver damage… [Read More]

New RheumPAC Chair Zachary Wallace, MD, MSc, Promotes a Louder Voice for Rheumatology

A patient Zachary Wallace, MD, MSc, met during his third year of medical school at Georgetown University helped lead him to his passion for rheumatology…. [Read More]

View More Latest News »